ATE534405T1 - Entzündungshemmendes analgetikum für die äussere anwendung - Google Patents

Entzündungshemmendes analgetikum für die äussere anwendung

Info

Publication number
ATE534405T1
ATE534405T1 AT05704361T AT05704361T ATE534405T1 AT E534405 T1 ATE534405 T1 AT E534405T1 AT 05704361 T AT05704361 T AT 05704361T AT 05704361 T AT05704361 T AT 05704361T AT E534405 T1 ATE534405 T1 AT E534405T1
Authority
AT
Austria
Prior art keywords
external use
inflammatory analgesic
present
skin
etodolac
Prior art date
Application number
AT05704361T
Other languages
English (en)
Inventor
Hidetoshi Hamamoto
Masaki Ishibashi
Sueko Matsumura
Keiko Yamasaki
Original Assignee
Medrx Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medrx Co Ltd filed Critical Medrx Co Ltd
Application granted granted Critical
Publication of ATE534405T1 publication Critical patent/ATE534405T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Botany (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT05704361T 2004-01-29 2005-01-27 Entzündungshemmendes analgetikum für die äussere anwendung ATE534405T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004021232 2004-01-29
PCT/JP2005/001540 WO2005072775A1 (ja) 2004-01-29 2005-01-27 消炎鎮痛外用剤

Publications (1)

Publication Number Publication Date
ATE534405T1 true ATE534405T1 (de) 2011-12-15

Family

ID=34823785

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05704361T ATE534405T1 (de) 2004-01-29 2005-01-27 Entzündungshemmendes analgetikum für die äussere anwendung

Country Status (10)

Country Link
US (1) US7655687B2 (de)
EP (1) EP1716868B1 (de)
KR (1) KR101074374B1 (de)
CN (1) CN1909929B (de)
AT (1) ATE534405T1 (de)
AU (1) AU2005209110B2 (de)
CA (1) CA2554751C (de)
ES (1) ES2372959T3 (de)
WO (1) WO2005072775A1 (de)
ZA (1) ZA200606824B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005072775A1 (ja) 2004-01-29 2005-08-11 Medrx Co., Ltd. 消炎鎮痛外用剤
AU2006302237C1 (en) * 2005-10-07 2012-11-08 The University Of Alabama Multi-functional ionic liquid compositions
US20100029704A1 (en) * 2007-01-29 2010-02-04 Medrx Co., Ltd. Salt of nonsteroidal anti-inflammatory drug and organic amine compound and use thereof
JP4620168B2 (ja) * 2007-12-11 2011-01-26 株式会社 メドレックス イオン液体化したエトドラクのテープ剤
WO2011010456A1 (ja) * 2009-07-24 2011-01-27 株式会社ネクスト２１ ＮＳＡＩＤｓ含有外用剤及び当該外用剤の製造方法
ES3034911T3 (en) 2011-05-10 2025-08-26 Itochu Chemical Frontier Corp Non-aqueous patch
JP5856153B2 (ja) 2011-05-10 2016-02-09 伊藤忠ケミカルフロンティア株式会社 非水性貼付剤
US11786455B2 (en) 2011-05-10 2023-10-17 Itochu Chemical Frontier Corporation Non-aqueous patch
SI2823815T1 (sl) 2011-09-27 2018-09-28 Itochu Chemical Frontier Corporation Ne-vodni obliž

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6440420U (de) 1987-09-04 1989-03-10
CA2178686A1 (en) * 1995-06-13 1996-12-14 Leslie G. Humber Oral formulations of s(+)-etodolac
WO2001047559A1 (fr) 1999-12-27 2001-07-05 Teikoku Seiyaku Co., Ltd Pastilles a usage externe
JP4684404B2 (ja) * 2000-10-26 2011-05-18 第一三共株式会社 消炎鎮痛外用剤組成物
US20030129208A1 (en) 2002-01-07 2003-07-10 Alberts David S. Topical application of alpha-DFMO and anti-inflammatory drug for treatment of actinic keratoses
JP2003335663A (ja) * 2002-05-20 2003-11-25 Medorekkusu:Kk 消炎鎮痛外用剤
WO2003099293A1 (en) * 2002-05-23 2003-12-04 Danmarks Farmaceutiske Universitet Pharmacologically active salts
US7166641B2 (en) * 2002-10-02 2007-01-23 Yung Shin Pharmaceutical Industrial Co., Ltd. Pharmaceutically acceptable salts containing local anesthetic and anti-inflammatory activities and methods for preparing the same
JP2005082512A (ja) 2003-09-05 2005-03-31 Medorekkusu:Kk イオン性の薬物の経皮吸収性を高めた外用剤
WO2005072775A1 (ja) 2004-01-29 2005-08-11 Medrx Co., Ltd. 消炎鎮痛外用剤
JP4807721B2 (ja) 2004-01-29 2011-11-02 株式会社 メドレックス 消炎鎮痛外用剤

Also Published As

Publication number Publication date
CN1909929B (zh) 2011-04-20
ZA200606824B (en) 2007-12-27
CA2554751C (en) 2012-05-29
EP1716868A1 (de) 2006-11-02
WO2005072775A1 (ja) 2005-08-11
AU2005209110A1 (en) 2005-08-11
US20070054952A1 (en) 2007-03-08
ES2372959T3 (es) 2012-01-30
AU2005209110B2 (en) 2010-07-01
US7655687B2 (en) 2010-02-02
KR20060121213A (ko) 2006-11-28
KR101074374B1 (ko) 2011-10-17
EP1716868A4 (de) 2009-07-15
CA2554751A1 (en) 2005-08-11
EP1716868B1 (de) 2011-11-23
CN1909929A (zh) 2007-02-07

Similar Documents

Publication Publication Date Title
CZ2006579A3 (cs) Kožní mikroaktivační systém
AU300211S (en) Surgical aiming device
CR10167A (es) "uso de derivados de sulfamida heterociclica benzo-fusionada para el tratamiento de dolor"
CY1111177T1 (el) Ενωση φαινοθειαζινιου για επουλωση τραυματων
LU92484I2 (fr) Paclitaxel formulé comme albumine liée à des nanoparticules
EA200970870A1 (ru) Новое терапевтическое применение 1-[2-(2,4-диметилфенилсульфанил)фенил]пиперазина
ATE441635T1 (de) 4-cyanopyrazol-3-carbonsäureamidderivate, herstellung und therapeutische anwendung davon
CR20110318A (es) Compuestos, composición farmacéutica y métodos para utilizarse en el tratamiento de trastornos metabólicos
WO2007095615A3 (en) Use of benzo-heteroaryl sulfamide derivatives for the treatmentof pain
ATE534405T1 (de) Entzündungshemmendes analgetikum für die äussere anwendung
ATE491399T1 (de) Chirurgisches schneidinstrument
EP1781277A4 (de) Kombinationspräparat
CY1111588T1 (el) Υποκατεστημενα καρβοξαμιδια ως ανταγωνιστες μεταβολοτροπου υποδοχεα ομαδας ι
AR044350A1 (es) Manguito y parche analgesico microencapsulado de uso topico para el tratamiento del dolor
PT1572178E (pt) Tratamento de mastalgia com 4-hidroxi-tamoxifeno
DE502006002773D1 (de) Verwendung von Pelargonium Extrakten in Kombination mit Plantago zur Herstellung eines Medikaments zur Behandlung der Rachenentzündung
BRPI0519218A2 (pt) reduÇço do crescimento de cabelos ou pÊlos
ATE501719T1 (de) Methoden und zusammensetzungen zur beruhigung von mund- und nasenschleimhäuten
EA200970798A1 (ru) Композиция для лечения диабета 2 типа
GB0606015D0 (en) therapeutic agents
WO2006083667A3 (en) Treatment of oxygen induced inflammatory tissue injury
AU302062S (en) A clip for a furling channel
ATE375787T1 (de) Zusammensetzung enthaltend antiphlogistisch und analgetisch wirkende bestandteile zur topischen anwendung am tierischen bewegungsapparat
NO20062138L (no) Anvendelse av ifenprodil i behandling av smerte
AU304714S (en) Men's briefs